Skip to main content

Advertisement

Fig. 3 | Biomarker Research

Fig. 3

From: Evaluation of two high-throughput proteomic technologies for plasma biomarker discovery in immunotherapy-treated melanoma patients

Fig. 3

Correlation of common protein targets. a List of the 49 proteins shared by the SOMAscan and Discovery Assays. b The median relative fluorescence units (RFU) of each of the 49 proteins in all 47 patient samples were derived from the SOMAscan and Discovery assays and tested for correlation (Spearman’s rank correlation coefficient; r = 0.3165, p = 0.0267). Twelve of the 49 proteins (represented in red) showed significant positive correlation between the two assays when tested individually using Spearman’s rank correlation coefficient (results of the statistical analysis shown in Table 4)

Back to article page